Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, 9/16 August 2014, Vol 293, No 7822/3

Sort by: Newest first Oldest first A-Z Z-A

  • Verifying genuine pharmaceutical products will be difficult to implement Subscription

    7 AUG 2014 10:15 By Umakant Patel
    Comments (1)

    In most big IT projects software providers have over promised and under delivered and at a far higher final cost. I do not believe it will be any different when it comes to verifying genuine pharmaceutical products (2014;293:587). One billion items are dispensed every year. Assuming it takes one second to check each item physically, this equates to about 280,000 hours of labour.

  • A safe service does not mean it is a good service Subscription

    7 AUG 2014 10:15

    “Surely pharmacists should have been consulted?” writes Graham Phillips (2014;293:85) in his blog about the new General Pharmaceutical Council (GPhC) inspection model for community pharmacies. He considers it unjustified to conclude that only 1 in 30 pharmacies in the UK is “good”. In fact, pharmacists were consulted. I was on the

  • Is it not time registered pharmacy technicians are allowed to join the RPS? Subscription

    7 AUG 2014 10:14 By Howard McNulty

    As one of many who advocated that registered pharmacy technicians should be able to join the new professional body for pharmacy in the past, I was disappointed that the then new Royal Pharmaceutical Society decided not to allow it.

  • Tuesday 2 December: RCN/Royal Pharmaceutical Society Joint Conference Subscription

    7 AUG 2014 10:13

    “Working Together to Help Patients Make the most of Medicines” by the RPS and the RCN. Confirmed speakers include Simon O-Neill, Director of Care Policy and Intelligence, Diabetes UK. Royal College of Nursing, 20 Cavendish Square, London W1G 0RN. Buffet 12.40pm, meeting 9.30am–16.30pm.

  • Zameer Choudrey, CEO of Bestway Group

    Bestway aims high in the UK pharmacy market

    5 AUG 2014 20:30 By Elizabeth Sukkar

    How will Bestway, new owner of the UK’s third largest pharmacy chain, perform in the pharmacy market? And, crucially, will it change the Co-operative business model?

  • Genomics biomarker good practice consultation Subscription

    5 AUG 2014 17:06

    The European Medicines Agency (EMA) has produced a concept paper for consultation on good practice in the use of genomic data and biomarkers in medicines development and safety monitoring. Responses to the consultation should be sent to

  • Gastro-oesophageal reflux in children and young people Subscription

    5 AUG 2014 16:28

    The National Institute of Health and Care Excellence (NICE) has published draft guidance on the recognition, diagnosis and management of gastro-oesophageal reflux disease in children and young people. This includes gastro-oesophageal reflux in babies. The guidance is open for consultation on the NICE website until 25 September 2014.

  • Preregistration survey Subscription

    5 AUG 2014 16:22

    The General Pharmaceutical Council (GPhC) has launched a preregistration survey for trainees who sat the registration assessment on 27 June 2014 and undertook preregistration training in the 2013/2014 training year. The survey will help to improve the GPhC’s understanding of key trends, issues and themes in preregistration training. It is part of a three-year project that started with their first survey of preregistration trainees in 2013. The survey is available on the

  • Contraindications for Eviplera Subscription

    5 AUG 2014 16:22

    Additions have been made to the list of mutations that exclude patients with HIV from treatment with Eviplera (emtricitabine/rilpivirine/tenofovir; Gilead). These are the tenofovir resistance-associated substitution K70E, and the combination of L100I+K103N as a rilpivirine resistance-associated substitution.

  • Drug tariff price updates: July 2014 Subscription

    5 AUG 2014 15:21

    The Department of Health and National Assembly for Wales have agreed concessionary prices for the following items for July 2014 prescriptions: loperamide capsules 2mg, now £2.13; hydrocortisone tablets 10mg, now £58.52; pizotifen tablets 500μg and 1.5mg, now £7.50 and £7.60, respectively.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.